Nigel Cunliffe

UK, University of Liverpool

Nigel Cunliffe is a professor of medical microbiology and head of the Department of Clinical Infection, Microbiology and Immunology at the Institute of Infection and Global Health, University of Liverpool. Dr. Cunliffe has investigated rotavirus infections in children since 1996, when he spent a year as visiting Fellow in the Viral Gastroenteritis Section at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia.

Dr. Cunliffe has principally focussed his research efforts addressing the epidemiology and prevention of rotavirus gastroenteritis in children in Malawi. He led a pivotal clinical trial in Malawi that demonstrated the efficacy of the monovalent human rotavirus vaccine in preventing severe rotavirus gastroenteritis, which informed WHO’s global rotavirus vaccine recommendation. He has recently led a research program in Malawi that has demonstrated the real-world clinical and cost effectiveness of rotavirus vaccine following its introduction into Malawi’s immunisation programme in 2012.

Currently, Dr. Cunliffe is assessing the impact of routine rotavirus vaccination in Merseyside, UK. He has published over 100 scientific papers, predominantly on rotavirus. Dr. Cunliffe obtained his medical degree from the University of Manchester in 1988 and his PhD from the University of Liverpool in 2001.



The ROTA Council was created in collaboration with an advisory group of 24 child health leaders from around the world. We promote the use of rotavirus vaccines as part of a comprehensive approach to addressing diarrheal disease.

logo-ivac logo-jhu
  • Stay up to date with the Rotavirus Organization of Technical Allies (ROTA)
    Sign up for the latest updates on rotavirus immunization-related science, policy, and access from the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health.
  • This field is for validation purposes and should be left unchanged.
Subscribe to our newsletter